Expanding Access to Oral Preexposure Prophylaxis for People Who Inject Drugs in Bayelsa and Niger States, Nigeria.


Journal

Global health, science and practice
ISSN: 2169-575X
Titre abrégé: Glob Health Sci Pract
Pays: United States
ID NLM: 101624414

Informations de publication

Date de publication:
28 02 2023
Historique:
received: 19 08 2022
accepted: 17 01 2023
pubmed: 1 3 2023
medline: 3 3 2023
entrez: 28 2 2023
Statut: epublish

Résumé

While oral preexposure prophylaxis (PrEP) is recommended for all individuals with substantial risk of acquiring HIV, people who inject drugs (PWID) have not been prioritized for oral PrEP services in most settings. The Meeting Targets and Maintaining Epidemic Control (EpiC) project implemented a comprehensive community-based program to increase access to and uptake of oral PrEP services among PWID in Bayelsa and Niger States, Nigeria. EpiC established partnerships with community-based organizations working with the PWID community, identified hotspots (common locations for socialization and drug use), and engaged PWID in tailoring oral PrEP services. The HIV prevention package provided in hotspots and drop-in centers included HIV testing, oral PrEP, postexposure prophylaxis, sexually transmitted infection screening and management, condoms and lubricants, PWID-specific risk reduction counseling, and referrals to other support programs. At drop-in centers, paralegal and psychological services were also provided. Peer outreach workers led outreach efforts. All PWID who tested HIV negative were eligible for oral PrEP screening. National oral PrEP eligibility criteria included: no suspicion of acute HIV infection, absence of proteinuria, and willingness to use oral PrEP as prescribed. We used descriptive analysis of routine programmatic data to illustrate program outcomes. From January 2020 to September 2021, 13,286 HIV tests were completed for PWID. Of these, 12,111 (91.16%) had negative results. Among those testing negative, 8,190 (67.62%) were screened for oral PrEP eligibility, and 2,661 (32.49%) were eligible. A total of 2,659 PWID (100% [312/312] among eligible females; 99.91% [2,347/2,349] among eligible males) initiated oral PrEP. Provision of oral PrEP services to PWID in Nigeria is feasible through a peer-led, differentiated, and holistic approach that addresses structural barriers among the PWID community. Greater efforts are needed to understand the needs and barriers to better tailor HIV services to reach females and other subpopulations in this community that are harder to reach.

Identifiants

pubmed: 36853631
pii: GHSP-D-22-00370
doi: 10.9745/GHSP-D-22-00370
pmc: PMC9972381
pii:
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Nishimoto et al.

Références

PLoS One. 2021 Feb 25;16(2):e0247352
pubmed: 33630909
AIDS Behav. 2015 May;19(5):752-7
pubmed: 25086669
PLoS One. 2012;7(1):e28238
pubmed: 22247757
Curr HIV/AIDS Rep. 2015 Mar;12(1):145-63
pubmed: 25589380
BMC Public Health. 2019 Sep 2;19(1):1210
pubmed: 31477063
AIDS Behav. 2021 May;25(5):1490-1506
pubmed: 32749627
Lancet. 2013 Jun 15;381(9883):2060-2
pubmed: 23769217
Lancet. 2013 Jun 15;381(9883):2083-90
pubmed: 23769234

Auteurs

Lirica Nishimoto (L)

FHI 360, New York, NY, USA. lnishimoto@fhi360.org.

Patrick Ikani (P)

FHI 360, Abuja, Nigeria.

Joseph Achanya (J)

Achieving Health Nigeria Initiative, Abuja, Nigeria.

Adekunle Idowu (A)

Achieving Health Nigeria Initiative, Abuja, Nigeria.

Adaobi Lisa Olisa (AL)

FHI 360, Abuja, Nigeria.

Christa Fischer Walker (CF)

FHI 360, Washington, DC, USA.

Amy Gottlieb (A)

FHI 360, Washington, DC, USA.

Christopher Akolo (C)

FHI 360, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH